Provider perspectives on challenges in treatment during psychedelic therapy

Keyphrases

• Clinical Trials 100%
• Provider Perspectives 100%
• Inpatient Treatment 100%
• Psychological Support 100%
• Free Response 100%
• Psychedelic Treatments 100%
• Psychedelic-assisted Therapy 100%
• Clinical Practice Guidelines 50%
• Improved Outcomes 50%
• Anonymous Survey 50%
• US States 50%
• Treatment Challenges 50%
• Traumatic Experiences 50%
• Psychedelics 50%
• Dysphoria 50%
• Psychiatric Interventions 50%
• Qualitative Thematic Analysis 50%
• Prior Trauma 50%
• Serious Mental Illness 50%
• During Treatment 50%
• Psilocybin 50%
• Clinical Report 50%
• Treatment Sessions 50%
• Personal Contact 50%

Psychology

• Psychodysleptic 100%
• Psychotomimetic 100%
• Clinical Trial 60%
• Thematic Analysis 40%
• Mental Illness 20%
• Post Traumatic Stress Disorder 20%
• Traumatic Experience 20%
• Economic and Social Development 20%
• United States of America 20%

Medicine and Dentistry

• Psychotomimetic 100%
• Clinical Trial 60%
• Clinical Guideline 20%
• Psilocybine 20%
• Posttraumatic Stress Disorder 20%
• Dysphoria 20%
• Neurodevelopmental Disorder 20%